Evidence map›Paper›PMID 37414936›Full record

ArticleNature biotechnology2024

De novo detection of somatic mutations in high-throughput single-cell profiling data sets.

Francesc Muyas, Carolin M Sauer, Jose Espejo Valle-Inclán, Ruoyan Li, Raheleh Rahbari, Thomas J Mitchell, Sahand Hormoz, Isidro Cortés-Ciriano

Abstract read
In one paragraph

Article in Nature biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Reconstruction of Cell Diversity and Cell Lineages from Somatic Mutations in Single-Cell Transcriptomic Data.DNA research : an international journal for rapid publication of reports on genes and genomes · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Disease insights from brain somatic mosaicism.Experimental & molecular medicine · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Morphogen Gradients as Drivers of Mosaicism During Early Human Development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesc MuyasEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
Carolin M SauerEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.ORCID http://orcid.org/0000-0003-2168-6630
Jose Espejo Valle-InclánEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.ORCID http://orcid.org/0000-0002-4857-5984
Ruoyan LiWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Raheleh RahbariWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Thomas J MitchellWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID http://orcid.org/0000-0003-0761-9503
Sahand HormozDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.
Isidro Cortés-CirianoEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK. icortes@ebi.ac.uk.ORCID http://orcid.org/0000-0002-2036-494X

Funding

Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasmsR01HL158269 · NHLBI · DANA-FARBER CANCER INST · PI HORMOZ, SAHAND · 2021 to 2025
$2.3M
Cancer Research UK 27176NHLBI NIH HHS R01 HL158269Wellcome Trust
6 · The paper itself

Abstract

Characterization of somatic mutations at single-cell resolution is essential to study cancer evolution, clonal mosaicism and cell plasticity. Here, we describe SComatic, an algorithm designed for the detection of somatic mutations in single-cell transcriptomic and ATAC-seq (assay for transposase-accessible chromatin sequence) data sets directly without requiring matched bulk or single-cell DNA sequencing data. SComatic distinguishes somatic mutations from polymorphisms, RNA-editing events and artefacts using filters and statistical tests parameterized on non-neoplastic samples. Using >2.6 million single cells from 688 single-cell RNA-seq (scRNA-seq) and single-cell ATAC-seq (scATAC-seq) data sets spanning cancer and non-neoplastic samples, we show that SComatic detects mutations in single cells accurately, even in differentiated cells from polyclonal tissues that are not amenable to mutation detection using existing methods. Validated against matched genome sequencing and scRNA-seq data, SComatic achieves F1 scores between 0.6 and 0.7 across diverse data sets, in comparison to 0.2-0.4 for the second-best performing method. In summary, SComatic permits de novo mutational signature analysis, and the study of clonal heterogeneity and mutational burdens at single-cell resolution.

Indexed as

High-Throughput Nucleotide SequencingMutationSingle-Cell AnalysisAlgorithmsHumansNeoplasms

Identifiers

PMID37414936
PMCPMC11098751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.